Keros Therapeutics, Inc. (KROS)
20.26
+0.13
(+0.65%)
USD |
NASDAQ |
Dec 19, 16:00
20.21
-0.05
(-0.25%)
After-Hours: 20:00
Keros Therapeutics Shareholders Equity (Quarterly): 703.58M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Pfizer Inc. | 92.80B |
| Innoviva, Inc. | 1.010B |
| Ocugen, Inc. | 3.533M |
| Bionano Genomics, Inc. | 49.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 742.78M |
| Total Liabilities (Quarterly) | 39.20M |
| Debt to Equity Ratio | 0.0248 |
| Current Ratio | 29.86 |
| Net Debt Paydown Yield | -0.11% |